Furuno T, Yamasaki F, Yokoyama T, Sato K, Sato T, Doi Y
Heart Vessels. 2010; 26(3):267-73.
PMID: 21063876
DOI: 10.1007/s00380-010-0054-8.
Mayr F, Jilma B
Wien Med Wochenschr. 2006; 156(17-18):472-80.
PMID: 17041802
DOI: 10.1007/s10354-006-0330-5.
Andaluz N, Zuccarello M
CNS Drugs. 2005; 19(7):597-622.
PMID: 15984896
DOI: 10.2165/00023210-200519070-00003.
Benesch C
Curr Atheroscler Rep. 2003; 5(4):267-75.
PMID: 12793967
DOI: 10.1007/s11883-003-0049-3.
Diener H, Ringleb P
Curr Treat Options Cardiovasc Med. 2002; 4(5):429-440.
PMID: 12194815
DOI: 10.1007/s11936-002-0022-4.
Choices in medical management for prevention of acute ischemic stroke.
Fleck J, Biller J
Curr Neurol Neurosci Rep. 2002; 1(1):33-8.
PMID: 11898498
DOI: 10.1007/s11910-001-0075-x.
Evaluation and management of acute ischemic stroke.
Bendixen B, Ocava L
Curr Cardiol Rep. 2002; 4(2):149-57.
PMID: 11827639
DOI: 10.1007/s11886-002-0028-2.
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
BMJ. 2002; 324(7329):71-86.
PMID: 11786451
PMC: 64503.
DOI: 10.1136/bmj.324.7329.71.
Is acetylsalicylic acid plus dipyridamole superior to ASA alone for secondary prevention of stroke?.
Dalton B, Papoushek C, Evans M
Can Fam Physician. 2002; 47:2235-9.
PMID: 11768921
PMC: 2018453.
Antithrombotic Secondary Prevention After Stroke.
Diener H, Ringleb P
Curr Treat Options Neurol. 2001; 3(5):451-462.
PMID: 11487459
DOI: 10.1007/s11940-001-0033-6.
Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia.
Algra A, van Gijn J
J Neurol Neurosurg Psychiatry. 1996; 60(2):197-9.
PMID: 8708654
PMC: 1073805.
DOI: 10.1136/jnnp.60.2.197.
Antiplatelet therapy--Part I.
Goodnight S, Coull B, McAnulty J, Taylor L
West J Med. 1993; 158(4):385-92.
PMID: 8317125
PMC: 1022066.
Platelet aggregation inhibitors in neurology.
Keyser A
Pharm World Sci. 1993; 15(6):243-51.
PMID: 8298583
DOI: 10.1007/BF01871125.
Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
BMJ. 1994; 308(6921):81-106.
PMID: 8298418
PMC: 2539220.
Antiplatelet drugs. A comparative review.
Schror K
Drugs. 1995; 50(1):7-28.
PMID: 7588091
DOI: 10.2165/00003495-199550010-00002.
